Financials Nissan Medical Industries Ltd

Equities

NISA

IL0006600196

Medical Equipment, Supplies & Distribution

Market Closed - TEL AVIV STOCK EXCHANGE 07:54:04 01/05/2024 pm IST 5-day change 1st Jan Change
1,392 ILa +0.36% Intraday chart for Nissan Medical Industries Ltd -1.28% +28.89%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 250.3 122.4 259.6 199 78.05 98.1
Enterprise Value (EV) 1 548.9 391.8 451.4 399.7 309.6 271.3
P/E ratio 9.97 x 7.79 x 4.57 x 5.57 x -2.16 x 17.4 x
Yield - - 3.5% 2.01% - -
Capitalization / Revenue 0.38 x 0.2 x 0.36 x 0.3 x 0.11 x 0.13 x
EV / Revenue 0.83 x 0.65 x 0.63 x 0.6 x 0.45 x 0.37 x
EV / EBITDA 6.32 x 5.99 x 3.28 x 4.56 x 13.9 x 3.12 x
EV / FCF 11.2 x 14.4 x 6.17 x -291 x -68.6 x 5.02 x
FCF Yield 8.94% 6.94% 16.2% -0.34% -1.46% 19.9%
Price to Book 1.46 x 0.71 x 1.24 x 0.87 x 0.36 x 0.43 x
Nbr of stocks (in thousands) 9,084 9,084 9,084 9,084 9,084 9,084
Reference price 2 27.56 13.47 28.58 21.91 8.593 10.80
Announcement Date 20/03/19 25/03/20 16/03/21 28/03/22 31/03/23 20/03/24
1ILS in Million2ILS
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 658.4 605.5 721.5 668.4 684.6 733.9
EBITDA 1 86.85 65.37 137.8 87.68 22.25 86.9
EBIT 1 60.67 36.68 110.3 65.81 -1.766 61.37
Operating Margin 9.21% 6.06% 15.29% 9.85% -0.26% 8.36%
Earnings before Tax (EBT) 1 50.56 30.91 110 70.45 -47.02 27.82
Net income 1 25.1 15.71 56.85 36.01 -36.05 5.649
Net margin 3.81% 2.59% 7.88% 5.39% -5.27% 0.77%
EPS 2 2.763 1.729 6.258 3.935 -3.970 0.6219
Free Cash Flow 1 49.1 27.21 73.13 -1.372 -4.512 54.04
FCF margin 7.46% 4.49% 10.14% -0.21% -0.66% 7.36%
FCF Conversion (EBITDA) 56.53% 41.62% 53.09% - - 62.19%
FCF Conversion (Net income) 195.59% 173.19% 128.65% - - 956.66%
Dividend per Share - - 1.000 0.4400 - -
Announcement Date 20/03/19 25/03/20 16/03/21 28/03/22 31/03/23 20/03/24
1ILS in Million2ILS
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 299 269 192 201 232 173
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.438 x 4.121 x 1.392 x 2.289 x 10.41 x 1.993 x
Free Cash Flow 1 49.1 27.2 73.1 -1.37 -4.51 54
ROE (net income / shareholders' equity) 16.3% 9.36% 31.1% 17.1% -14% 5.54%
ROA (Net income/ Total Assets) 5.29% 3.21% 9.92% 5.75% -0.15% 5.32%
Assets 1 474.9 488.7 573.2 626.3 23,953 106.2
Book Value Per Share 2 18.90 19.00 23.10 25.10 23.70 25.20
Cash Flow per Share 2 1.580 2.370 5.350 4.410 2.130 2.740
Capex 1 11.9 10.1 13.9 8.16 9.18 9.82
Capex / Sales 1.8% 1.67% 1.92% 1.22% 1.34% 1.34%
Announcement Date 20/03/19 25/03/20 16/03/21 28/03/22 31/03/23 20/03/24
1ILS in Million2ILS
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NISA Stock
  4. Financials Nissan Medical Industries Ltd